44 related articles for article (PubMed ID: 28475217)
1. Multiple-matrix metabolomics analysis for the distinct detection of colorectal cancer and adenoma.
Zhang Y; Ni M; Tao Y; Shen M; Xu W; Fan M; Shan J; Cheng H
Metabolomics; 2024 Apr; 20(3):47. PubMed ID: 38642214
[TBL] [Abstract][Full Text] [Related]
2. Identification of urinary biomarkers of colorectal cancer: Towards the development of a colorectal screening test in limited resource settings.
Zhang L; Zheng J; Ismond KP; MacKay S; LeVatte M; Constable J; Isaac Alatise O; Peter Kingham T; Wishart DS
Cancer Biomark; 2023; 36(1):17-30. PubMed ID: 35871322
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic characterization of colorectal cancer cell lines highlighting stage-specific alterations during cancer progression.
Yusof HM; Ab-Rahim S; Wan Ngah WZ; Nathan S; A Jamal AR; Mazlan M
Bioimpacts; 2021; 11(2):147-156. PubMed ID: 33842285
[No Abstract] [Full Text] [Related]
4. Amino Acid Profiles in the Biological Fluids and Tumor Tissue of CRC Patients.
Santos MD; Barros I; Brandão P; Lacerda L
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201497
[TBL] [Abstract][Full Text] [Related]
5. Rewiring carbohydrate catabolism differentially affects survival of pancreatic cancer cell lines with diverse metabolic profiles.
Tataranni T; Agriesti F; Ruggieri V; Mazzoccoli C; Simeon V; Laurenzana I; Scrima R; Pazienza V; Capitanio N; Piccoli C
Oncotarget; 2017 Jun; 8(25):41265-41281. PubMed ID: 28476035
[TBL] [Abstract][Full Text] [Related]
6. A relative quantitative positive/negative ion switching method for untargeted lipidomics via high resolution LC-MS/MS from any biological source.
Breitkopf SB; Ricoult SJH; Yuan M; Xu Y; Peake DA; Manning BD; Asara JM
Metabolomics; 2017 Mar; 13(3):. PubMed ID: 28496395
[TBL] [Abstract][Full Text] [Related]
7. Tissue metabolic profiling reveals major metabolic alteration in colorectal cancer.
Shen Y; Sun M; Zhu J; Wei M; Li H; Zhao P; Wang J; Li R; Tian L; Tao Y; Shen P; Zhang J
Mol Omics; 2021 Jun; 17(3):464-471. PubMed ID: 33881127
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer diagnostic model utilizing metagenomic and metabolomic data of stool microbial extracellular vesicles.
Kim DJ; Yang J; Seo H; Lee WH; Ho Lee D; Kym S; Park YS; Kim JG; Jang IJ; Kim YK; Cho JY
Sci Rep; 2020 Feb; 10(1):2860. PubMed ID: 32071370
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia.
van Vorstenbosch R; Cheng HR; Jonkers D; Penders J; Schoon E; Masclee A; van Schooten FJ; Smolinska A; Mujagic Z
Metabolites; 2022 Dec; 13(1):. PubMed ID: 36676980
[TBL] [Abstract][Full Text] [Related]
10. Untargeted GC-MS-Based Metabolomics for Early Detection of Colorectal Cancer.
Zhu G; Wang Y; Wang W; Shang F; Pei B; Zhao Y; Kong D; Fan Z
Front Oncol; 2021; 11():729512. PubMed ID: 34804922
[TBL] [Abstract][Full Text] [Related]
11. Urinary charged metabolite profiling of colorectal cancer using capillary electrophoresis-mass spectrometry.
Udo R; Katsumata K; Kuwabara H; Enomoto M; Ishizaki T; Sunamura M; Nagakawa Y; Soya R; Sugimoto M; Tsuchida A
Sci Rep; 2020 Dec; 10(1):21057. PubMed ID: 33273632
[TBL] [Abstract][Full Text] [Related]
12. A gas chromatography-mass spectrometry (GC-MS) metabolomic approach in human colorectal cancer (CRC): the emerging role of monosaccharides and amino acids.
Barberini L; Restivo A; Noto A; Deidda S; Fattuoni C; Fanos V; Saba L; Zorcolo L; Mussap M
Ann Transl Med; 2019 Dec; 7(23):727. PubMed ID: 32042743
[TBL] [Abstract][Full Text] [Related]
13. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.
Ning W; Li H; Meng F; Cheng J; Song X; Zhang G; Wang W; Wu S; Fang J; Ma K; Yang J; Pei D; Dong F
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475217
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
16. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review.
Zhang F; Zhang Y; Zhao W; Deng K; Wang Z; Yang C; Ma L; Openkova MS; Hou Y; Li K
Oncotarget; 2017 May; 8(21):35460-35472. PubMed ID: 28389626
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
